Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1129–1152 of 121,433 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: UMEC/VI, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years and older
Enrollment: 498 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 11
States / cities: Phoenix, Arizona • Upland, California • Clearwater, Florida + 8 more

Conditions: Chronic Kidney Diseases
Interventions: Zibotentan, Dapagliflozin, Placebo, Dapagliflozin and Zibotentan; Drug
Lead sponsor: University Medical Center Groningen; Other
Eligibility: 18 Years to 75 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: HIV Infections
Interventions: Amprenavir; Drug
Lead sponsor: Glaxo Wellcome; Industry
Eligibility: 4 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Attention Deficit Hyperactivity Disorder Symptoms
Interventions: Behavioral/organizational skills intervention augmented with digital health application; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 11 Years to 15 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Postoperative Pain
Interventions: Oral Acetaminophen, Intravenous acetaminophen; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Temporomandibular Joint Dysfunction Syndrome
Interventions: ultrasound; Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older · Female only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Psychosis, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Schizoaffective Disorder
Interventions: Computerized Cognitive Training; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 15 Years to 45 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Wrinkle, Skin Red
Interventions: 16 weeks mango intake; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 50 Years to 70 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Davis, California

Conditions: Stroke
Interventions: Thigh Cuff; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 50 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Mindfulness; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 20 Years to 75 Years · Female only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Lower Extremity Weakness Distal, Distorted; Balance
Interventions: Assessment and education, Healthy Steps with Falls Case Management, Healthy Steps in Motion; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 50 Years to 100 Years
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Gastric Surgery
Interventions: Not listed
Lead sponsor: Jeffrey Hazey; Other
Eligibility: 18 Years to 70 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: High Risk Pregnancy
Interventions: MRI, MRI - IUGR; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 379 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Portland, Oregon • Salt Lake City, Utah

Conditions: To Verify Tissue Heating and Temperature Stability and Safety Throughout RF Treatment Duration Applied on the Face
Interventions: NuEra Tight RF system; Device
Lead sponsor: Lumenis Be Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 2
States / cities: Detroit, Michigan • New York, New York

Conditions: Inpatient Facililty Diagnoses
Interventions: New Standardized Accept Note, Existing Transfer Patient Admission Process; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1,658 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sick Sinus Syndrome, Complete Heart Block, Syncope, Chronic Systolic Heart Failure
Interventions: polymixin/bacitracin, cephalexin, or levofloxacin, or clindamycin, Saline; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,010 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Breast Cancer, Vitamin D Deficiency
Interventions: Not listed
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Genetic Differences of Lipid Metabolism/Healthy Subjects
Interventions: soybean oil and borage oil; Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 21 Years to 65 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Diabetes Mellitus, Type 2
Interventions: GSK189075, pioglitazone, Placebo; Drug · Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 14
States / cities: Mesa, Arizona • Hollywood, Florida • Miami, Florida + 9 more

Conditions: Schizophrenia
Interventions: LY2140023, Aripiprazole; Drug
Lead sponsor: Denovo Biopharma LLC; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Garden Grove, California • Glendale, California

Conditions: Atherosclerosis, Coronary Artery Disease, Cardiovascular Disease
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 34,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2016
U.S. locations: 11
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Miami, Florida + 6 more

Conditions: Cardiac Output
Interventions: Not listed
Lead sponsor: Transonic Systems Inc.; Industry
Eligibility: Up to 16 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Sickle Cell Disease, Asthma, Acute Chest Syndrome
Interventions: Budesonide inhalation suspension; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 1 Year to 4 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sickle Cell Disease, Vaso-Occlusive Crisis
Interventions: Ketamine; Drug
Lead sponsor: UCSF Benioff Children's Hospital Oakland; Other
Eligibility: 10 Years to 25 Years
Enrollment: 62 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Oakland, California

Search by objective public record fields.

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

A Study of Amprenavir in HIV-Infected Patients

Development of a Mobile App for an Executive Functioning Intervention for Adolescents

Efficacy of Oral vs. Intravenous Acetaminophen

Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia

State Representation in Early Psychosis - Project 4

Influence of Mango Intake of Skin Health in Postmenopausal Women

Non-invasive Measurement of Cerebral Dynamic Autoregulation

Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy

Assessment and Referral Versus Exercise in Primary Prevention of Falls: PA Healthy Steps Program

Testing for Bacterial Contamination During Gastric Surgeries

Placenta Imaging Project

Evaluation of Thermal Outcome and Safety of Nuera Tight RF System

Optimizing the Safety of Inter-Hospital Transfer

Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.

Epidemiological Analysis of Vitamin D and Breast Cancer Risk in Saudi Arabian Women

Botanical Oils Study to Determine Genetic Differences in the Way Your Body Processes Fats in Edible Oils

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

A Study of Safety and Tolerability in Subjects With Schizophrenia

COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter Registry (CONFIRM)

Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients

Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial

Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis